1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea has been researched along with Esophageal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egami, H; Hayashi, N; Kurizaki, T; Ogawa, M; Ohmachi, H; Okino, T; Schalkwijk, J; Shibata, Y; Yamamoto, S | 1 |
1 other study(ies) available for 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Esophageal Neoplasms
| Article | Year |
|---|---|
Immunohistochemical expression of SKALP/elafin in squamous cell carcinoma of the oesophagus.
Topics: Carcinoma, Squamous Cell; DNA Fragmentation; DNA, Neoplasm; Esophageal Neoplasms; Esophagus; Humans; Immunohistochemistry; Mucous Membrane; Neoplasm Proteins; Nitrosourea Compounds; Proteinase Inhibitory Proteins, Secretory; Proteins; Serine Proteinase Inhibitors | 1997 |